Effective 3/1: New Requirements for the Prescription Monitoring Program (PMP)

Date: 02/21/20

Beginning March 1, 2020, all pharmacists and prescribers (other than a veterinarians) will be required by the Texas State Board of Pharmacy to check patients' Prescription Monitoring Program (PMP) history before dispensing or prescribing opioids, benzodiazepines, barbiturates or carisoprodol.

All Texas-licensed pharmacies are required to report all dispensed controlled substances records to the Texas PMP no later than the next business day after the prescription is filled. This reporting requirement applies to all Schedule II, III, IV and V controlled substances. Pharmacies who fail to report are subject to an administrative, civil or criminal penalty.

Pharmacists and prescribers are encouraged to check the PMP to help eliminate duplicate and overprescribing of controlled substances, as well as to obtain critical controlled substance history information. 

Overview of the PMP

The Texas PMP collects and monitors prescription data for all Schedule II, III, IV and V Controlled Substances (CS) dispensed by a pharmacy in Texas, or to a Texas resident from a pharmacy located in another state. The PMP also provides a database for monitoring patient prescription history for practitioners and the ordering of Texas Schedule II Official Prescription Forms. 

To access the Texas PMP, please visit https://texas.pmpaware.net/login. Additional PMP resources are located at https://www.pharmacy.texas.gov/PMP/.

For questions regarding the program, please email texaspmp@pharmacy.texas.gov, or call 512-305-8050.